PT Kalbe Farma Tbk. (PTKFY) Stock Price, Analysis & Data
Intrinsic Value
Analyst Forecast
Stock Forecasts →Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | — | n/a | n/a |
| EPS | — | n/a | n/a |
Metrics
- Bid
- 8.2
- Market Cap
- 1.9B
- Revenue (ttm)
- n/a
- Net Income (ttm)
- n/a
- -0.07
- 0.9
- 9.32
- n/a
- P/B (ttm)
- 0.02
- P/S (ttm)
- n/a
- Earnings Date
- n/a
- Ask
- 9
- Volume
- 422
- Avg. Volume (20D)
- 364
- Open
- 8.50
- Previous Close
- 8.39
- Day's Range
- 8.50 - 8.60
- 52-Week Range
- 7.63 - 16.36
- Analyst
- n/a
- Price Target
- n/a
- Dividends
- $0.22 (2.65%)
- Ex-Dividend Date
- Jun 5, 2026
About PT Kalbe Farma Tbk.
View profile →PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.